NextCure Inc (NXTC)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$5.12-12.48%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · NXTC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | — | — | — | — | — | — | 22.4 | 6.3 |
| Operating Expenses & Income | ||||||||
| R&D Expenses | 27.2 | 44.9 | 41.5 | 47.9 | 54.2 | 50.2 | 46.6 | 34.2 |
| Operating Income | (43.9) | (57.6) | (59.7) | (67.6) | (75.9) | (70.8) | (41.2) | (37.5) |
| Earnings from Continuing Operations | ||||||||
| Interest Expense | — | — | — | — | — | — | 0.2 | 0.2 |
| Net Income | ||||||||
| Net Income | (42.7) | (55.8) | (55.7) | (62.7) | (74.7) | (69.4) | (36.6) | (33.7) |
| Per Share | ||||||||
| Basic EPS | (8.05) | (19.65) | (1.99) | (2.25) | (2.69) | (2.51) | (1.33) | — |
| Diluted EPS | (8.05) | (19.65) | (1.99) | (2.25) | (2.69) | (2.51) | (1.33) | — |
| Dividend per Share | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Avg Shares | 5.3 | 2.8 | 28.0 | 27.8 | 27.7 | 27.6 | 27.5 | — |
| Diluted Weighted Avg Shares | 5.3 | 2.8 | 28.0 | 27.8 | 27.7 | 27.6 | 27.5 | — |
| Supplemental | ||||||||
| EBITDA | — | (55.4) | (56.8) | (63.9) | (71.8) | (66.5) | (37.8) | (34.8) |
| EBIT | (43.9) | (57.6) | (59.7) | (67.6) | (75.9) | (70.8) | (41.2) | (37.5) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.